Large-scale testing (Phase 3)Study completedNCT02721069What this trial is testingRepeat Dose Safety Study of NRL-1 in Epilepsy SubjectsWho this might be right forAcute Repetitive SeizuresBreakthrough Seizures Neurelis, Inc. 175